1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with trelstar in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (trelstar) | Trials (trelstar) | Recent Studies (post-2010) (trelstar) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 1,998 | 483 | 490 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amiel, ML; Benveniste, J; Testart, J | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and trelstar
Article | Year |
---|---|
Platelet-activating factor-acether is a component of human follicular fluid.
Topics: Adult; Animals; Buserelin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menotropins; Oocytes; Platelet Activating Factor; Platelet Aggregation; Rabbits; Triptorelin Pamoate | 1991 |